[Antitumor activity and preclinical pharmacologic evaluation of pingyangmycin (author's transl)].
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D001761:Bleomycin / Q000627:therapeutic use* / Q000031:analogs & derivatives; D002279:Carcinoma 256, Walker / Q000188:drug therapy; D004285:Dogs; D004938:Esophageal Neoplasms / Q000188:drug therapy; D008114:Liver Neoplasms, Experimental / Q000188:drug therapy; D008545:Melanoma / Q000188:drug therapy; D051379:Mice; D009374:Neoplasms, Experimental / Q000188:drug therapy*; D051381:Rats; D012510:Sarcoma 180 / Q000188:drug therapy; D012511:Sarcoma 37 / Q000188:drug therapy
D000903:Antibiotics, Antineoplastic; D001761:Bleomycin; C021771:zhengguangmycin